|
1
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: Primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14:(Suppl 5). v1–v49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brat DJ, Scheithauer BW, Fuller GN and
Tihan T: Newly codified glial neoplasms of the 2007 WHO
Classification of Tumours of the Central Nervous System:
Angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain
Pathol. 17:319–324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weller M, van den Bent M, Hopkins K, Tonn
JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D,
Henriksson R, Balana C, et al: European Association for
Neuro-Oncology (EANO) Task Force on Malignant Glioma: EANO
guideline for the diagnosis and treatment of anaplastic gliomas and
glioblastoma. Lancet Oncol. 15:e395–e403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Noritake J, Watanabe T, Sato K, Wang S and
Kaibuchi K: IQGAP1: A key regulator of adhesion and migration. J
Cell Sci. 118:2085–2092. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mataraza JM, Briggs MW, Li Z, Entwistle A,
Ridley AJ and Sacks DB: IQGAP1 promotes cell motility and invasion.
J Biol Chem. 278:41237–41245. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johnson M, Sharma M and Henderson BR:
IQGAP1 regulation and roles in cancer. Cell Signal. 21:1471–1478.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Watanabe T, Wang S, Noritake J, Sato K,
Fukata M, Takefuji M, Nakagawa M, Izumi N, Akiyama T and Kaibuchi
K: Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin
filaments during cell polarization and migration. Dev Cell.
7:871–883. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nabeshima K, Shimao Y, Inoue T and Koono
M: Immunohistochemical analysis of IQGAP1 expression in human
colorectal carcinomas: Its overexpression in carcinomas and
association with invasion fronts. Cancer Lett. 176:101–109. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miyoshi T, Shirakusa T, Ishikawa Y,
Iwasaki A, Shiraishi T, Makimoto Y, Iwasaki H and Nabeshima K:
Possible mechanism of metastasis in lung adenocarcinomas with a
micropapillary pattern. Pathol Int. 55:419–424. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin X, Liu Y, Liu J, Lu W, Liang Z, Zhang
D, Liu G, Zhu H, Xu N and Liang S: The overexpression of IQGAP1 and
β-catenin is associated with tumor progression in hepatocellular
carcinoma in vitro and in vivo. PLoS One. 10:e01337702015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jadeski L, Mataraza JM, Jeong HW, Li Z and
Sacks DB: IQGAP1 stimulates proliferation and enhances
tumorigenesis of human breast epithelial cells. J Biol Chem.
283:1008–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hayashi H, Nabeshima K, Aoki M, Hamasaki
M, Enatsu S, Yamauchi Y, Yamashita Y and Iwasaki H: Overexpression
of IQGAP1 in advanced colorectal cancer correlates with poor
prognosis-critical role in tumor invasion. Int J Cancer.
126:2563–2574. 2010.PubMed/NCBI
|
|
13
|
Casteel DE, Turner S, Schwappacher R,
Rangaswami H, Su-Yuo J, Zhuang S, Boss GR and Pilz RB: Rho
isoform-specific interaction with IQGAP1 promotes breast cancer
cell proliferation and migration. J Biol Chem. 287:38367–38378.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McDonald KL, O'Sullivan MG, Parkinson JF,
Shaw JM, Payne CA, Brewer JM, Young L, Reader DJ, Wheeler HT, Cook
RJ, et al: IQGAP1 and IGFBP2: Valuable biomarkers for determining
prognosis in glioma patients. J Neuropathol Exp Neurol. 66:405–417.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stengel K and Zheng Y: Cdc42 in oncogenic
transformation, invasion, and tumorigenesis. Cell Signal.
23:1415–1423. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sakurai-Yageta M, Recchi C, Le Dez G,
Sibarita J-B, Daviet L, Camonis J, D'Souza-Schorey C and Chavrier
P: The interaction of IQGAP1 with the exocyst complex is required
for tumor cell invasion downstream of Cdc42 and RhoA. J Cell Biol.
181:985–998. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goel R, Muthusamy B, Pandey A and Prasad
TS: Human protein reference database and human proteinpedia as
discovery resources for molecular biotechnology. Mol Biotechnol.
48:87–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brandt DT, Marion S, Griffiths G, Watanabe
T, Kaibuchi K and Grosse R: Dia1 and IQGAP1 interact in cell
migration and phagocytic cup formation. J Cell Biol. 178:193–200.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang S, Xu Y, Shen G, Zhao X, Zhou J, Li
X, Gong F, Ling B, Fang L, Huang C, et al: Gene expression and
methylation status of 14-3-3sigma in human renal carcinoma tissues.
IUBMB Life. 60:534–540. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu W, Wang X, Liu J, He Y, Liang Z, Xia Z,
Cai Y, Zhou L, Zhu H and Liang S: Downregulation of ARHGDIA
contributes to human glioma progression through activation of Rho
GTPase signaling pathway. Tumour Biol. Oct 10–2016.(Epub ahead of
print). doi: 10.1007/s13277-016-5374-6.
|
|
22
|
Liang S and Shen G: Biomarkers of
gliomaMolecular Targets of CNS Tumors. ISBN:
978-953-307-736-9Garami M: InTech Press; Rijeka: pp. 325–342.
2011
|
|
23
|
Ma R, de Pennington N, Hofer M, Blesing C
and Stacey R: Diagnostic and prognostic markers in gliomas - an
update. Br J Neurosurg. 27:311–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
von Deimling A, Korshunov A and Hartmann
C: The next generation of glioma biomarkers: MGMT methylation, BRAF
fusions and IDH1 mutations. Brain Pathol. 21:74–87. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gerstner ER, Yip S, Wang DL, Louis DN,
Iafrate AJ and Batchelor TT: Mgmt methylation is a prognostic
biomarker in elderly patients with newly diagnosed glioblastoma.
Neurology. 73:1509–1510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong P, Nabeshima K, Nishimura N, Kawakami
T, Hachisuga T, Kawarabayashi T and Iwasaki H: Overexpression and
diffuse expression pattern of IQGAP1 at invasion fronts are
independent prognostic parameters in ovarian carcinomas. Cancer
Lett. 243:120–127. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakamura H, Fujita K, Nakagawa H, Kishi F,
Takeuchi A, Aute I and Kato H: Expression pattern of the scaffold
protein IQGAP1 in lung cancer. Oncol Rep. 13:427–431.
2005.PubMed/NCBI
|
|
28
|
Balenci L, Clarke ID, Dirks PB, Assard N,
Ducray F, Jouvet A, Belin MF, Honnorat J and Baudier J: IQGAP1
protein specifies amplifying cancer cells in glioblastoma
multiforme. Cancer Res. 66:9074–9082. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
White CD, Brown MD and Sacks DB: IQGAPs in
cancer: A family of scaffold proteins underlying tumorigenesis.
FEBS Lett. 583:1817–1824. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li H, Eishingdrelo A, Kongsamut S and
Eishingdrelo H: G-protein-coupled receptors mediate 14-3-3 signal
transduction. Signal Transduct Target Ther. 1:160182016.doi:
10.1038/sigtrans.2016.18. View Article : Google Scholar
|
|
31
|
Chi AS, Sorensen AG, Jain RK and Batchelor
TT: Angiogenesis as a therapeutic target in malignant gliomas.
Oncologist. 14:621–636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sanson M: Editorial review: Targets for
glioma treatment: from bench to bedside. Curr Opin Oncol.
20:650–651. 2008. View Article : Google Scholar : PubMed/NCBI
|
